These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3362238)

  • 1. [The course of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion].
    Hooymans JM; van Ballegooie E; Reitsma WD; Schweitzer NM
    Ned Tijdschr Geneeskd; 1988 Apr; 132(14):624-8. PubMed ID: 3362238
    [No Abstract]   [Full Text] [Related]  

  • 2. [Course of diabetic retinopathy and metabolic control with subcutaneous insulin infusion pump: 18-month study].
    Goicolea I; Santamaría E; Pardo C; Vázquez JA; Martín A; Castresana I
    An Med Interna; 1989 Feb; 6(2):71-3. PubMed ID: 2491075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical course of advanced microvascular complications in diabetic patients undergoing long-term treatment with the subcutaneous insulin infusion pump].
    Calle Pascual AL; Charro Salgado AL
    Med Clin (Barc); 1983 Dec; 81(20):904-7. PubMed ID: 6664146
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term insulin treatment using continuous subcutaneous insulin infusions: metabolic control and hemorheological aspects].
    Lombardo A; Scornavacca G; Scavino S; Oliva G; Cacciola R; Amantia L; Motta L
    Minerva Endocrinol; 1987; 12(4):289-300. PubMed ID: 3696102
    [No Abstract]   [Full Text] [Related]  

  • 5. [Continuous subcutaneous insulin infusion: long-term treatment in an unselected group of insulin-dependent diabetics].
    Waldhäusl W; Freyler H; Bratusch-Marrain P; Vierhapper H; Bruneder H
    Dtsch Med Wochenschr; 1983 Apr; 108(15):570-7. PubMed ID: 6404620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetic retinopathy with continuous subcutaneous insulin infusion therapy (insulin pump)].
    Bernsmeier H; Sonnenberg GE
    Fortschr Ophthalmol; 1984; 81(3):267-70. PubMed ID: 6479784
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin pumps--still a research tool?
    Lauritzen T; Pramming S
    Ann Clin Res; 1984; 16(2):98-106. PubMed ID: 6380393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuous subcutaneous insulin infusion].
    Araki H; Makino H; Yoshida S
    Nihon Rinsho; 1990 Dec; 48 Suppl():1038-43. PubMed ID: 2086865
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetic renal-retinal syndrome: does tight control help?
    Cowan CL
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):86-9. PubMed ID: 3551259
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intensified insulin therapy by multiple injections or by pump].
    Pernet A
    Schweiz Med Wochenschr; 1986 Jan; 116(3):77-82. PubMed ID: 3511525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery.
    Navascués I; Kerner W; Pfeiffer EF
    Life Support Syst; 1985; 3(3):263-7. PubMed ID: 3900596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the insulin pump in children.
    Cornwell S; MacDonald MJ
    Prim Care; 1983 Dec; 10(4):723-50. PubMed ID: 6371865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in therapy for insulin-dependent diabetes mellitus.
    Mintz DH
    Med Sect Proc; 1993; ():157-69. PubMed ID: 8078868
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes.
    Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS
    Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Unstable type I diabetes mellitus: comparative study between intensive conventional treatment and continuous subcutaneous infusion of insulin].
    Levy I; Bergua M; Esmatjes E; Halperin I; Figuerola D
    Med Clin (Barc); 1984 Oct; 83(13):525-8. PubMed ID: 6392766
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes control and complications. Where do we go from here?
    Ratner RE
    Online J Curr Clin Trials; 1993 Jun; Doc No 68():[996 words; 6 paragraphs]. PubMed ID: 8313018
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
    Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and efficacy of long-term treatment by continuous subcutaneous insulin infusion (CSII) in insulin-dependent diabetes.
    Van Ballegooie E; Reitsma WD; Sluiter WJ; Doorenbos H
    Neth J Med; 1984; 27(5):185-92. PubMed ID: 6427640
    [No Abstract]   [Full Text] [Related]  

  • 19. Fulfilling the promise of insulin pump therapy in childhood diabetes.
    Tamborlane WV
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():4-10. PubMed ID: 16774611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Continuous subcutaneous insulin infusion; the first decade].
    Doorenbos H
    Ned Tijdschr Geneeskd; 1987 Jan; 131(3):91-3. PubMed ID: 3821988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.